BTI
JAZZ icon

Blue Trust Inc’s Jazz Pharmaceuticals JAZZ Stock Holding History

Blue Trust Inc’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$568K Buy
3,003
+10
+0.3% +$1.75K 0.01% 449
2025
Q4 		$509K Sell
2,993
-268
-8% -$41.1K 0.01% 475
2025
Q3 		$430K Buy
3,261
+109
+3% +$13.1K ﹤0.01% 537
2025
Q2 		$334K Buy
3,152
+200
+7% +$21.7K ﹤0.01% 595
2025
Q1 		$366K Buy
2,952
+1,185
+67% +$155K ﹤0.01% 500
2024
Q4 		$218K Buy
1,767
+750
+74% +$88.4K ﹤0.01% 615
2024
Q3 		$109K Sell
1,017
-290
-22% -$31.8K ﹤0.01% 1179
2024
Q2 		$157K Buy
1,307
+257
+24% +$28.3K ﹤0.01% 800
2024
Q1 		$126K Buy
1,050
+1,036
+7,400% +$127K ﹤0.01% 646
2023
Q4 		$2K Buy
+14
New +$1.75K ﹤0.01% 2160
2023
Q3 		– Sell
-6
Closed -$1K – 2165
2023
Q2 		$1K Sell
6
-37
-86% -$4.98K ﹤0.01% 1865
2023
Q1 		$7K Buy
+43
New +$6.36K ﹤0.01% 1699
2022
Q4 		– Sell
-5
Closed -$1K – 2347
2022
Q3 		$1K Hold
5
– – ﹤0.01% 1939
2022
Q2 		$1K Buy
+5
New +$770 ﹤0.01% 1789

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Blue Trust Inc's JAZZ Position: Q1 2026 in Review

Blue Trust Inc increased its Jazz Pharmaceuticals (JAZZ) stake by 0.33% in Q1 2026, buying an estimated $1.75K and bringing the position to 3,003 shares worth $568K. The position accounts for 0.01% of the portfolio, ranked #449.

Blue Trust Inc first reported a position in JAZZ in Q2 2022 and has held it in 14 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Blue Trust Inc held 3,003 shares of Jazz Pharmaceuticals worth $568K as of Q1 2026.
  • Blue Trust Inc bought 10 Jazz Pharmaceuticals shares in Q1 2026, an estimated $1.75K.
  • Jazz Pharmaceuticals made up 0.01% of Blue Trust Inc's portfolio in Q1 2026, its #449 holding.
  • Blue Trust Inc first reported a position in Jazz Pharmaceuticals in Q2 2022 and has held it in 14 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.